The Regulatory Path Forward for CBD
Print this Article | Send to Colleague
''The prevalence of questionable products may inspire a tsunami of class action litigation..." The regulatory path forward for CBD
03-Jun-2019 By Elaine Watson
While not everyone was on the same page about the legal path forward for hemp-derived CBD during Friday’s marathon FDA hearing, multiple speakers made clear that the current situation is untenable, with one predicting a wave of lawsuits, and others demanding that the agency either crack down on companies marketing such products, or explicitly spell out that existing regulatory frameworks can accommodate them.
https://www.foodnavigator-usa.com/Article/2019/06/03/What-s-the-regulatory-path-forward-for-CBD
